FI962806A - Käsittely, jossa käytetään arakidonhappometaboliitin ja hiukkasen muodostamia formulaatioita - Google Patents

Käsittely, jossa käytetään arakidonhappometaboliitin ja hiukkasen muodostamia formulaatioita Download PDF

Info

Publication number
FI962806A
FI962806A FI962806A FI962806A FI962806A FI 962806 A FI962806 A FI 962806A FI 962806 A FI962806 A FI 962806A FI 962806 A FI962806 A FI 962806A FI 962806 A FI962806 A FI 962806A
Authority
FI
Finland
Prior art keywords
formulations
particles
treatment
arachidonic acid
acid metabolite
Prior art date
Application number
FI962806A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962806A0 (fi
Inventor
Andrew S Janoff
David F Eierman
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of FI962806A0 publication Critical patent/FI962806A0/fi
Publication of FI962806A publication Critical patent/FI962806A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Dispersion Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI962806A 1994-01-11 1996-07-10 Käsittely, jossa käytetään arakidonhappometaboliitin ja hiukkasen muodostamia formulaatioita FI962806A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17973994A 1994-01-11 1994-01-11
US20334194A 1994-02-28 1994-02-28
PCT/US1995/000370 WO1995018620A1 (en) 1994-01-11 1995-01-11 Treatment using arachidonic acid metabolite and particulate formulations

Publications (2)

Publication Number Publication Date
FI962806A0 FI962806A0 (fi) 1996-07-10
FI962806A true FI962806A (fi) 1996-09-10

Family

ID=26875610

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962806A FI962806A (fi) 1994-01-11 1996-07-10 Käsittely, jossa käytetään arakidonhappometaboliitin ja hiukkasen muodostamia formulaatioita

Country Status (7)

Country Link
EP (1) EP0738151A1 (ja)
JP (1) JPH10507737A (ja)
AU (1) AU682753B2 (ja)
CA (1) CA2179986A1 (ja)
FI (1) FI962806A (ja)
NO (1) NO962911L (ja)
WO (1) WO1995018620A1 (ja)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2128343T3 (es) * 1991-05-07 1999-05-16 Liposome Co Inc Formulaciones de prostaglandina liposomica.
DE4125255A1 (de) * 1991-07-31 1993-02-04 Knoll Ag Prostaglandin e (pfeil abwaerts)1(pfeil abwaerts)-formulierung

Also Published As

Publication number Publication date
NO962911L (no) 1996-09-03
FI962806A0 (fi) 1996-07-10
AU682753B2 (en) 1997-10-16
WO1995018620A1 (en) 1995-07-13
CA2179986A1 (en) 1995-07-13
EP0738151A1 (en) 1996-10-23
JPH10507737A (ja) 1998-07-28
NO962911D0 (no) 1996-07-10
AU1601895A (en) 1995-08-01

Similar Documents

Publication Publication Date Title
KR960703646A (ko) 게임 장치 및 게임의 리플레이 방법(Game Apparatus and Method of Replaying Game)
DE69505657D1 (de) Fluorcarbonetherhybriden enthaltende physiologich akzeptabele emulsionen und verwendungsverfahren
NO20001754D0 (no) Prostaglandinagonister og anvendelse derav for behandling av benforstyrrelser
EE03742B1 (et) Tramadooli mitmikühikulised preparaadid ja nende valmistamismeetod
TR199600498A2 (tr) S(+)-ibuprofen'in oral formülasyonlari.
NO972972D0 (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
NO20004098D0 (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
PT769965E (pt) Formulacoes aquosas de risperidona
FI971171A0 (fi) Koostumukset ja menetelmät syöttösolujen välittämien tulehdussairauksien hoitamiseksi
DK0862431T3 (da) Anvendelse af pædiatrisk farmaceutisk formulering omfattende amoxycillin og clavulanat
TR199600499A2 (tr) S(+)-Etodolak'in oral formülasyonlari.
DE59711379D1 (de) Oral applizierbare formulierungen von chinolon- oder naphthyridoncarbonsäuren
KR880700673A (ko) 골손상 치료용방법 및 조성물
FI934857A (fi) Foerriktning av bindningspar in vivo
NO20001412D0 (no) Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser
DK0776658T3 (da) Kosmetiske og/eller farmaceutiske præparater indeholdende sukkertensider og partielle glycerider af fedtsyrer
NO973193D0 (no) Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer
ITMI932728A0 (it) Formulazioni diagnostiche paramagnetiche e metodo d'uso delle stesse
NO974486D0 (no) Lavdoserte "Ridogrel"-formuleringer samt anvendelse derav ved behandling av tarmbetennelse
FI962806A0 (fi) Käsittely, jossa käytetään arakidonhappometaboliitin ja hiukkasen muodostamia formulaatioita
FR2807560B1 (fr) Procede et appareil d'edition d'images representatives d'idees
FR2685867B1 (fr) Compositions contre la desquamation de l'epiderme et du cuir chevelu.
NO307285B1 (no) Anvendelse av eliprodil og enantiomerer derav for fremstilling av medisinske preparater
IT1276684B1 (it) Formulazioni idrosolubili di collagenasi stabilizzata e procedimento per la loro preparazione
NO962782L (no) Farmasöytiske formuleringer omfattende polytiourea, og metode for anvendelse derav